Nifedipine ER 30 mg: Uses, Side Effects, and Precautions

Nifedipine ER 30 mg is an extended-release calcium channel blocker prescribed mainly for high blood pressure and chronic angina, the chest pain caused by reduced blood flow to the heart. The “ER” (extended-release) designation matters more than it might seem: it controls how the drug enters your bloodstream, which directly shapes both its effectiveness and its side-effect profile. Because nifedipine relaxes the smooth muscle in blood vessel walls, its therapeutic window is wide, stretching into several off-label uses that range from Raynaud’s phenomenon to preterm labor management.

How Nifedipine Works

Nifedipine belongs to the dihydropyridine class of calcium channel blockers. Smooth muscle cells in your arteries need calcium to contract; nifedipine blocks the channels those calcium ions flow through, so the muscle relaxes and the vessel widens. The result is lower blood pressure and better blood flow to the heart muscle. Unlike some other calcium channel blockers (verapamil and diltiazem, for instance), nifedipine acts almost exclusively on blood vessels rather than on the heart’s electrical system, which is why it does not slow heart rate the way those drugs can.

Research has also shown that nifedipine does more than simply relax vessels in the moment. In lab and animal models, it inhibited changes in vascular smooth muscle cells that drive thickening of artery walls after injury, partly by dampening a signaling pathway involved in cell growth. At concentrations too low to change blood pressure, nifedipine still suppressed the overgrowth of tissue inside damaged arteries.¹ That finding is mainly relevant to researchers studying atherosclerosis, but it underscores that nifedipine’s effects on blood vessels go beyond a simple on-off relaxation switch.

Why the Extended-Release Formulation Matters

Original nifedipine capsules released the drug quickly, producing a sharp spike in blood levels. That spike brought fast blood-pressure drops but also triggered reflex increases in heart rate, flushing, and headaches. The extended-release tablet was designed to solve this. In a pharmacokinetic study of healthy volunteers, plasma levels of nifedipine from an ER formulation rose slowly, peaking around eight and a half hours after the dose, and the drug remained detectable in the blood a full 24 hours later.² That slow, sustained release is what allows once-daily dosing and a much smoother blood-pressure profile throughout the day.

Some ER tablets use an osmotic-pump mechanism: a laser-drilled hole in a hard outer shell lets water seep in and push the drug out at a controlled rate. Others rely on a coating that dissolves gradually depending on the pH of the gut. Both designs aim for the same goal, but they can behave slightly differently when other medications change your stomach chemistry. A clinical study found that taking omeprazole (a common acid-reducing drug) for a week before a nifedipine dose raised nifedipine blood levels modestly for both formulation types, likely because omeprazole inhibits the same liver enzyme that breaks nifedipine down.³ The increase was in the range of 12 to 33 percent, enough to be worth knowing about but not usually enough to require a dose change on its own.

The “Ghost Tablet” in Your Stool

If you take an osmotic-pump version of nifedipine ER and spot what looks like an intact pill in your stool, don’t panic. The outer shell of the tablet is designed to pass through you whole after the drug has been released. A case report documented a patient who mistook these shells for parasites.⁴ The pill did its job; the empty husk is just the delivery vehicle. This is one of the more common reasons people call their pharmacist after starting nifedipine ER, and it is completely harmless.

Approved Uses

High Blood Pressure

Nifedipine ER 30 mg is a standard starting dose for adults with hypertension. In a study of patients with mild to moderate high blood pressure, roughly 88 percent of those on the 30 mg dose achieved a seated diastolic blood pressure below 90 mm Hg, which was the predefined control threshold.⁵ The dose can be titrated upward to 60 mg or 90 mg daily if blood pressure remains above target, though side effects (especially ankle swelling) tend to increase with higher doses.

Chronic Stable and Vasospastic Angina

For people with angina caused by coronary artery spasm, nifedipine is one of the go-to drugs. A systematic review of calcium channel blockers for vasospastic angina found that nifedipine reduced the frequency of angina attacks noticeably by the fourth week of treatment.⁶ The same review noted that nifedipine could cause an excessive blood-pressure drop in some patients and a faster resting heart rate by the eighth week, so follow-up monitoring matters. In chronic stable angina (the more common type, triggered by exertion), nifedipine reduces the heart’s oxygen demand by lowering the resistance it pumps against.

Off-Label Uses

Raynaud’s Phenomenon

Raynaud’s causes fingers and toes to turn white or blue in response to cold or stress because small arteries clamp down excessively. Nifedipine, by widening those arteries, can reduce both the frequency and severity of these vasospastic attacks.⁷ While immediate-release nifedipine was studied first for this condition, extended-release formulations are now more commonly prescribed because the smoother drug levels reduce the likelihood of rebound vasospasm. Many rheumatologists consider nifedipine a first-line pharmacological option for Raynaud’s when lifestyle measures alone aren’t enough.

Preterm Labor

Nifedipine is widely used off-label as a tocolytic, a drug that slows or stops premature uterine contractions. Because it relaxes smooth muscle, it can quiet the uterus enough to buy time for corticosteroids to mature a baby’s lungs. In a randomized trial, about 88 percent of women given nifedipine loading doses had no uterine contractions 90 minutes later, compared with roughly 70 percent in the placebo group.⁸ At 48 hours, successful treatment was achieved in about 78 percent of the nifedipine group versus half of the placebo group. A separate observational study reported that nifedipine effectively prolonged pregnancy in about 85 percent of cases, with minimal side effects.⁹ Preclinical work has confirmed the mechanism: nifedipine significantly reduced both the frequency and the force of spontaneous contractions in human uterine muscle strips.¹⁰

Common Side Effects

Most of nifedipine ER’s side effects flow directly from the same mechanism that makes it useful: it relaxes blood vessels. When arteries widen but veins do not keep pace, fluid can shift out of blood vessels into surrounding tissue, and blood pressure at the surface can fluctuate.

Ankle and Lower-Leg Swelling

Peripheral edema is the most frequently reported complaint with nifedipine ER, occurring in roughly a quarter of patients at standard doses in some trials.¹¹ The swelling happens because nifedipine dilates arterioles much more than it dilates veins, creating a mismatch. Pressure builds in the tiny capillaries, and fluid leaks into the tissue around your ankles and feet.¹² This is not a sign of heart failure or kidney trouble; it is a local plumbing issue. That said, the distinction matters, and your prescriber should evaluate new swelling to rule out other causes. Adding an ACE inhibitor or ARB, which dilate the venous side as well, can sometimes counteract the problem.

Flushing, Headache, and Dizziness

Flushing and headache are classic vasodilatory side effects. In comparative trials, headache occurred in about 5 percent of patients on nifedipine GITS and flushing in a similar proportion, with dizziness showing up less frequently.¹¹ The extended-release formulation clearly improved tolerability compared to older capsule forms. Still, these symptoms are most common during the first week or two of treatment and often fade as the body adjusts.

Gum Overgrowth

A less well-known side effect is gingival hyperplasia, where the gum tissue between teeth becomes swollen and overgrown. It tends to occur with long-term use and appears to require an underlying inflammatory trigger such as plaque buildup. A clinical and lab study found that nifedipine alone did not directly cause gum cells to proliferate, suggesting that both local inflammation and the drug together are needed to produce the changes.¹³ Good oral hygiene, including regular dental cleanings, can reduce the risk substantially. If gum overgrowth does develop, switching to a different blood-pressure medication usually reverses it over a few months.

Drug Interactions to Watch For

Nifedipine is broken down primarily by the liver enzyme CYP3A4. Anything that inhibits this enzyme raises nifedipine levels in your blood, potentially amplifying both its blood-pressure-lowering effect and its side effects. Anything that revs up CYP3A4 can reduce nifedipine’s effectiveness.

Quinidine, a heart-rhythm drug still used occasionally, is a well-documented inhibitor of nifedipine metabolism. Biochemical research showed that quinidine doesn’t simply compete with nifedipine for the same spot on the enzyme. Instead, it shifts the enzyme into a different shape that can still bind nifedipine but can no longer break it down, acting as a kind of allosteric trap.¹⁴ Practically, this means quinidine can cause nifedipine to accumulate faster than expected.

Grapefruit juice is the most commonly encountered dietary interaction. It inhibits CYP3A4 in the intestinal wall, reducing how much nifedipine gets broken down before it reaches your bloodstream.¹⁵ The result can be a noticeable drop in blood pressure, dizziness, or worsened ankle swelling. If you take nifedipine ER regularly, it’s simplest to avoid grapefruit and grapefruit juice entirely rather than try to time the two apart.

Other strong CYP3A4 inhibitors to be aware of include certain antifungals (ketoconazole, itraconazole), macrolide antibiotics (erythromycin, clarithromycin), and some HIV protease inhibitors. On the flip side, potent CYP3A4 inducers like rifampin, carbamazepine, and phenytoin can reduce nifedipine levels enough to undermine blood-pressure control. If any of these drugs are started or stopped while you’re on nifedipine ER, your prescriber may need to adjust your dose.

Nifedipine in Pregnancy and Preeclampsia

Beyond its tocolytic use described earlier, nifedipine ER plays an increasingly studied role in managing blood pressure during preeclampsia. A randomized trial gave nifedipine ER to women during labor who had preeclampsia with severe features. Those who received the drug needed emergency treatment for dangerously high blood-pressure spikes about 34 percent of the time, compared with 55 percent in the placebo group.¹⁶ There was also a trend toward fewer cesarean deliveries and fewer neonatal intensive care admissions in the nifedipine group, though those differences did not reach clear statistical significance.

Dosing in preeclampsia has been debated. A separate trial compared a single daily 60 mg dose against a split 30 mg twice-daily regimen. Both achieved similar overall blood-pressure control, but the twice-daily dosing reduced the need for rescue treatment for sudden severe spikes, leading the investigators to favor that approach.¹⁷ For pregnant individuals, this is a practical detail worth discussing with an obstetrician, because how evenly the drug covers the full 24 hours can matter a great deal when blood pressure is volatile.

Don’t Stop Abruptly

One precaution that sometimes catches people off guard is the risk of rebound hypertension if nifedipine is stopped suddenly. A case report described a 71-year-old man whose blood pressure had stayed below 170/100 mm Hg on nifedipine and methyldopa for five months. Three days after nifedipine was discontinued, his blood pressure soared to 300/200 mm Hg, a life-threatening emergency.¹⁸ Not everyone will experience a rebound that dramatic, but the general rule with nifedipine ER is to taper the dose under medical supervision rather than quit cold turkey. If you need to stop the drug, talk to your prescriber about a step-down plan.

How Nifedipine ER Compares to Amlodipine

Amlodipine is the other widely prescribed dihydropyridine calcium channel blocker, and patients often wonder which is “better.” The short answer is that they lower blood pressure to roughly the same degree. A head-to-head trial demonstrated equivalent reductions in both systolic and diastolic blood pressure over 24-hour ambulatory monitoring.¹⁹ A real-world comparison in Taiwan likewise concluded that extended-release nifedipine and brand-name amlodipine had comparable clinical effectiveness for hypertension management.²⁰

The differences show up mainly in side effects. In a placebo-controlled comparison, the rate of adverse effects considered definitely or probably related to treatment was 41 percent for nifedipine retard versus 27 percent for amlodipine. Headache, flushing, and dizziness were all more common with nifedipine.²¹ However, in another trial using the GITS formulation specifically, the tolerability gap narrowed and amlodipine patients tended to develop edema and gastrointestinal symptoms somewhat later in the treatment course.¹⁹ In practice, the choice between the two often comes down to which side-effect profile is more acceptable for a given patient, whether the cost differs on a particular insurance plan, and whether the patient has conditions (like Raynaud’s or preterm labor risk) where nifedipine’s broader off-label evidence gives it an edge.

What Happens in an Overdose

Nifedipine overdose is uncommon but dangerous, and the primary concern is profound low blood pressure. In a reported case, a 54-year-old woman who took 300 mg of nifedipine (ten times the standard daily dose) developed severe hypotension and a fast heart rate. She was treated with intravenous fluids, calcium gluconate (to counteract the calcium-channel blockade directly), and a vasopressor drug. She did not develop heart-rhythm disturbances, low blood sugar, or damage to the heart muscle, and she recovered quickly.²² Treatment in an emergency setting focuses on aggressive fluid resuscitation, intravenous calcium, and vasopressors as needed. With extended-release formulations, the drug continues to be absorbed for hours, so monitoring has to extend well beyond the initial stabilization period. If you suspect an overdose, treat it as a medical emergency and call your local poison control center or go to the nearest emergency department.

Practical Storage and Handling Notes

Nifedipine is sensitive to light. The ER tablets should be stored in their original packaging at room temperature, away from direct sunlight or bright indoor light. If your pharmacy dispenses them in a clear bottle, ask whether an amber or opaque container would be better for long-term storage. You should swallow the tablet whole; crushing, chewing, or splitting an ER tablet defeats the controlled-release mechanism and can dump the entire dose at once, mimicking the old rapid-release capsule with all its side-effect problems. The 30 mg ER tablet is not scored and is not intended to be divided. If a lower or intermediate dose is needed, your prescriber should write for a different tablet strength rather than ask you to cut the one you have.

1
PubMed Central. Nifedipine inhibits vascular smooth muscle cell dedifferentiation via downregulation of Akt signaling
2
PubMed. Pharmacokinetics of a new extended-release nifedipine formulation following a single oral dose, in human volunteers
3
PubMed. Effect of Omeprazole Administration on the Pharmacokinetics of Oral Extended-Release Nifedipine in Healthy Subjects
4
PubMed Central. Undigested Pills in Stool Mimicking Parasitic Infection
5
Clinical Therapeutics. Blood pressure control in patients with mild to moderate essential hypertension switched from nifedipine gastrointestinal therapeutic system (GITS) 30 mg to nifedipine GITS 20 mg
6
BMJ Publishing Group Ltd. Comparison of various calcium antagonist on vasospastic angina: a systematic review
7
PubMed. Clinical and laboratory effects of nifedipine in Raynaud’s phenomenon
8
PubMed Central. Effectiveness of nifedipine in threatened preterm labor: a randomized trial
9
PubMed Central. Efficacy and Safety of Nifedipine as a Tocolytic Agent in Preterm Labor
10
Scientific Reports. Assessment of the tocolytic nifedipine in preclinical primary models of preterm birth
11
PubMed Central. Long-acting nifedipine in the management of the hypertensive patient
12
PubMed Central. Calcium channel blocker-related periperal edema: can it be resolved?
13
PubMed. Nifedipine-induced gingival hyperplasia: a clinical and in vitro study
14
Biochemical Pharmacology. Drug-drug interactions: Effect of quinidine on nifedipine binding to human cytochrome P450 3A4
15
PubMed Central. Clinical effects of grapefruit juice-nifedipine interaction in a 54-year-old Nigerian: a case report
16
PubMed. Trial of Intrapartum Extended-Release Nifedipine to Prevent Severe Hypertension Among Pregnant Individuals With Preeclampsia With Severe Features
17
PubMed. Daily Versus BID Nifedipine GITS in Severe Preeclampsia: Randomized Controlled Trial
18
PubMed. Hypertensive crisis associated with nifedipine withdrawal
19
Clinical Therapeutics. The antihypertensive efficacy and safety of once-daily nifedipine coat-core compared with once-daily amlodipine in mild-to-moderate essential hypertension
20
PubMed Central. Comparative efficacy of generic nifedipine versus brand‐name amlodipine for hypertension management in Taiwan
21
PubMed. Comparison of early side effects with amlodipine and nifedipine retard in hypertension
22
Wiley Online Library (Clin Cardiol). Nifedipine overdose